Full-Time
Manufacturing Operator
Posted on 8/20/2026
Fluxergy
51-200 employees
Portable diagnostic platform for rapid tests
Compensation Overview
$20 - $24/hr
No H1B Sponsorship
Irvine, CA, USA
In Person
 Operations & Logistics (1) |
|---|
Get referred to Fluxergy
See people who can refer or advise you
- Strong hand-eye coordination and attention to detail.
- Ability to operate machinery safely and responsibly.
- Demonstrated commitment to safe work practices when interacting with machinery.
- Ability to maintain a clean and organized workspace.
- Basic computer proficiency, including Microsoft Word, Excel, and PowerPoint.
- Ability to stand for extended periods during the workday.
- Assemble the components that make up the Test Card consumable with accuracy and consistency.
- Operate industrial and custom automation machinery safely and effectively.
- Follow established production procedures and detailed process work instructions.
- Inspect products to ensure they meet defined quality and performance specifications.
- Maintain accurate production records, logs, and documentation.
- Support daily production operations while maintaining high standards of safety and efficiency.
- Keep work areas, equipment, and machinery clean, organized, and production-ready.
- Assist with monitoring and maintaining product and material inventory levels.
- Collaborate with team members to maintain a smooth and productive workflow.
- Perform additional tasks or support duties as needed to meet production goals.
- Experience operating production or manufacturing equipment.
- Previous experience working in a manufacturing or production environment.
Fluxergy creates a portable diagnostic platform that lets healthcare providers, veterinarians (including equine), and food-safety teams run multiple diagnostic tests on a single device, delivering rapid results at point-of-care. The system combines the device with disposable test kits to perform various tests, from molecular assays like COVID-19 to other health and safety checks, and is designed for fast, on-site decision-making. Fluxergy differentiates itself by offering industry-specific applications and a scalable, end-to-end solution (device plus kits) that targets diverse PoC settings, backed by partnerships and validated through collaborations with institutions such as Mass General Brigham. The company aims to expand production and adoption to set new benchmarks in how quickly and reliably laboratory testing can be done in real-world environments.
Company Size
51-200
Company Stage
Series C
Total Funding
$49.5M
Headquarters
Irvine, California
Founded
2011
Get referred to Fluxergy
See people who can refer or advise you
Simplify's Take
What believers are saying
- Fluxergy presented a new multimodal point-of-care platform at ADLM in July 2025.
- The NIH NIAID partnership, announced November 2024, advances high-value STI testing.
- Its equine Strep equi assay and coming multiplex reagents broaden near-term commercial pathways.
What critics are saying
- Only the COVID-19 test has CE-IVD approval; everything else remains RUO.
- Commercialization still depends on clinical trials for STI, vaginosis, and metabolic panels.
- If NIH or DoD programs stall, Fluxergy lacks proven recurring revenue beyond niche assays.
What makes Fluxergy unique
- Fluxergy’s multimodal analyzer combines PCR, chemistry, and cytometry on one platform.
- The NIH NIAID collaboration validates Fluxergy’s sample-prep and STI assay development.
- Its equine and food-safety assay menu targets niche buyers ignored by larger IVD vendors.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Paid Vacation
Paid Sick Leave
Paid Holidays
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↑ 0%2 year growth
↓ -6%Fluxergy partners with National Institutes of Health.
Fluxergy started its commercial launch of its in-house PCR platform in late 2022 and is now being used in over 80 veterinary labs and referral hospitals in the US, Canada and EU.
"We are proud to offer an on-site solution and comprehensive laboratory training that can make a difference in how care providers navigate preventative and responsive pathogen testing.". .
IRVINE, CA., July 2, 2020 – California-based Fluxergy will work with Mass General Brigham (MGB), a major health system in Massachusetts, to further evaluate Fluxergy’s innovative Research Use Only (RUO) COVID-19 testing platform, designed to deliver accurate PCR test results in under one hour.
In March, Fluxergy announced that it was similarly working with a team at the University of California, San Diego, to evaluate its system for COVID-19 testing.